| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 3,000 | ₹1,14,000 |
| HNI / NII | 2 | 6,000 | ₹2,28,000 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII / HNI (Total) | — | 18,99,000 (47.45%) | — | ₹721.62 Cr |
| Retail Investors | — | 18,99,000 (47.45%) | — | ₹721.62 Cr |
| Total ** | — | 40,02,000 (100.00%) | — | ₹15,207.60 Cr |
| Market Maker * | — | 2,04,000 (5.10%) | — | ₹7.75 Cr |
| Metric | 31-Mar-20 | 31-Mar-21 | 31-Mar-22 |
|---|---|---|---|
| Revenue | 3054.85 | 3101.54 | 7276.58 |
| PAT | 5.90 | 2.42 | 116.69 |
| EBITDA | — | — | — |
| Net Worth | 54.75 | 57.17 | 173.86 |
| Total Assets | 1844.18 | 2479.34 | 3622.96 |
| Reserves | 51.25 | 53.67 | 170.36 |
| Borrowings | — | — | — |
Incorporated in 2011, Dipna Pharmachem Limited is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The Company also started selling chemicals on a commission basis in the Financial year 2022. The company conducts business in Ahmedabad and the surrounding area of Ahmedabad.
The company's product portfolio comprises 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovascular, Anti - Bacteria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other etc.
The company is supplying raw materials to pharmaceutical industries and the pharmaceutical industry falls under the essential business list declared by the Government.
Competitive Strengths :